EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare Costs

Valentina Perrone, Vanessa Innao, Stefania Mazzoni, Maria Cappuccilli iD, Margherita Andretta, Fausto Bartolini, Alessandro Chinellato, Stefania Dell'Orco, Fulvio Ferrante, Renato Lombardi, Romina Pagliaro, Loredana Ubertazzo und 2 weitere

ClinicoEconomics and Outcomes Research · 2026-06 · Volume 18 · 1-20

DOI: 10.2147/ceor.s598572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ClinicoEconomics and Outcomes Research, 2026-06. Verfasst von Valentina Perrone und 13 weiteren Autor:innen. Beteiligte Einrichtung: CliCon S.r.l. Società Benefit, Health Economics & Outcomes Research, Bologna, Italy. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

chronic lymphocytic leukemiafirst-line treatmenthealthcare costsibrutinibreal-world evidencetargeted therapy

Autor:innen und Institutionen

  • CliCon S.r.l. Società Benefit, Health Economics & Outcomes Research, Bologna, Italy.
  • Division of Hematology, Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione, A.R.N.A.S. Garibaldi, Catania, Italy.
  • UOC Assistenza Farmaceutica Territoriale, Azienda ULSS 8 Berica, Vicenza, Italy.
  • Dipartimento Farmaceutico USL Umbria 2 e Coordinatore della Cabina di Regia Regione Umbria sulla Governance Farmaceutica, Terni, Italy.
  • UOC Farmacia Ospedaliera Azienda ULSS 3 Serenissima, Venice, Italy.
  • UOC Farmaceutica Territoriale, ASL Roma 6, Albano Laziale, Rome, Italy.

ORCID-Profile: Maria Cappuccilli, Luca Degli Esposti

Zitieren

APA

Perrone, V., Innao, V., Mazzoni, S., Cappuccilli, M., Andretta, M., Bartolini, F., Chinellato, A., Dell'Orco, S., Ferrante, F., Lombardi, R., Pagliaro, R., Ubertazzo, L., Valpondi, P., & Degli Esposti, L. (2026). First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare Costs. ClinicoEconomics and Outcomes Research, Volume 18, 1-20. https://doi.org/10.2147/ceor.s598572

Vancouver

Perrone V, Innao V, Mazzoni S, Cappuccilli M, Andretta M, Bartolini F, et al. First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare Costs. ClinicoEconomics and Outcomes Research. 2026;Volume 18:1-20. doi:10.2147/ceor.s598572

BibTeX
@article{Perrone2026,
  author = {Perrone, Valentina and Innao, Vanessa and Mazzoni, Stefania and Cappuccilli, Maria and Andretta, Margherita and Bartolini, Fausto and Chinellato, Alessandro and Dell'Orco, Stefania and Ferrante, Fulvio and Lombardi, Renato and Pagliaro, Romina and Ubertazzo, Loredana and Valpondi, Paola and Degli Esposti, Luca},
  title = {First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare Costs},
  journal = {ClinicoEconomics and Outcomes Research},
  year = {2026},
  volume = {Volume 18},
  pages = {1--20},
  doi = {10.2147/ceor.s598572}
}
Kostenlos starten →